Hwasun has four workshops and eight production lines for API and formulation products, and has the advantage of Proton Pump Inhibitor API and sustained-release formulation. Main products have been distributed worldwide including EU and Japan. A CEP certificate was granted for Lansoprazole.
We keep close cooperation with leading universities and CRO companies. With a group of well-qualified technical talents, we develop new products and optimize existing products, and provide sustainable motivation for the company.
We focus on developing generic API and sustained-release formulation.